S&P 500   4,269.22 (-0.44%)
DOW   33,326.65 (-0.54%)
QQQ   359.69 (+0.40%)
AAPL   173.60 (+1.40%)
MSFT   320.05 (+1.36%)
META   305.32 (+1.70%)
GOOGL   133.62 (+2.11%)
AMZN   129.54 (+1.90%)
TSLA   249.68 (-0.22%)
NVDA   445.68 (+2.46%)
NIO   8.79 (-2.77%)
BABA   86.29 (-0.52%)
AMD   102.41 (-0.40%)
T   14.72 (-2.00%)
F   12.30 (-0.97%)
MU   67.74 (-0.43%)
CGC   0.74 (-5.61%)
GE   108.89 (-1.50%)
DIS   81.54 (+0.60%)
AMC   8.08 (+1.13%)
PFE   33.79 (+1.87%)
PYPL   58.80 (+0.58%)
NFLX   380.13 (+0.67%)
S&P 500   4,269.22 (-0.44%)
DOW   33,326.65 (-0.54%)
QQQ   359.69 (+0.40%)
AAPL   173.60 (+1.40%)
MSFT   320.05 (+1.36%)
META   305.32 (+1.70%)
GOOGL   133.62 (+2.11%)
AMZN   129.54 (+1.90%)
TSLA   249.68 (-0.22%)
NVDA   445.68 (+2.46%)
NIO   8.79 (-2.77%)
BABA   86.29 (-0.52%)
AMD   102.41 (-0.40%)
T   14.72 (-2.00%)
F   12.30 (-0.97%)
MU   67.74 (-0.43%)
CGC   0.74 (-5.61%)
GE   108.89 (-1.50%)
DIS   81.54 (+0.60%)
AMC   8.08 (+1.13%)
PFE   33.79 (+1.87%)
PYPL   58.80 (+0.58%)
NFLX   380.13 (+0.67%)
S&P 500   4,269.22 (-0.44%)
DOW   33,326.65 (-0.54%)
QQQ   359.69 (+0.40%)
AAPL   173.60 (+1.40%)
MSFT   320.05 (+1.36%)
META   305.32 (+1.70%)
GOOGL   133.62 (+2.11%)
AMZN   129.54 (+1.90%)
TSLA   249.68 (-0.22%)
NVDA   445.68 (+2.46%)
NIO   8.79 (-2.77%)
BABA   86.29 (-0.52%)
AMD   102.41 (-0.40%)
T   14.72 (-2.00%)
F   12.30 (-0.97%)
MU   67.74 (-0.43%)
CGC   0.74 (-5.61%)
GE   108.89 (-1.50%)
DIS   81.54 (+0.60%)
AMC   8.08 (+1.13%)
PFE   33.79 (+1.87%)
PYPL   58.80 (+0.58%)
NFLX   380.13 (+0.67%)
S&P 500   4,269.22 (-0.44%)
DOW   33,326.65 (-0.54%)
QQQ   359.69 (+0.40%)
AAPL   173.60 (+1.40%)
MSFT   320.05 (+1.36%)
META   305.32 (+1.70%)
GOOGL   133.62 (+2.11%)
AMZN   129.54 (+1.90%)
TSLA   249.68 (-0.22%)
NVDA   445.68 (+2.46%)
NIO   8.79 (-2.77%)
BABA   86.29 (-0.52%)
AMD   102.41 (-0.40%)
T   14.72 (-2.00%)
F   12.30 (-0.97%)
MU   67.74 (-0.43%)
CGC   0.74 (-5.61%)
GE   108.89 (-1.50%)
DIS   81.54 (+0.60%)
AMC   8.08 (+1.13%)
PFE   33.79 (+1.87%)
PYPL   58.80 (+0.58%)
NFLX   380.13 (+0.67%)
NASDAQ:EVLO

Evelo Biosciences (EVLO) News Today

$3.74
-0.18 (-4.59%)
(As of 02:07 PM ET)
Compare
Today's Range
$3.63
▼
$4.01
50-Day Range
$3.68
▼
$13.31
52-Week Range
$0.49
▼
$48.40
Volume
56,238 shs
Average Volume
386,129 shs
Market Capitalization
$70.42 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$63.33
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media
SourceHeadline
marketbeat.com logoInvestors Buy High Volume of Put Options on Evelo Biosciences (NASDAQ:EVLO)
marketbeat.com - August 24 at 1:41 AM
seekingalpha.com logoEvelo Biosciences down 39% as 13M share offering begins
seekingalpha.com - August 18 at 12:41 PM
marketbeat.com logo
marketbeat.com - August 18 at 10:15 AM
marketbeat.com logo
marketbeat.com - August 18 at 9:36 AM
finanznachrichten.de logoEvelo Biosciences, Inc.: Evelo Biosciences Announces Second Quarter Financial Results and Recent Business Highlights
finanznachrichten.de - August 14 at 9:24 AM
finance.yahoo.com logoEvelo Biosciences Announces Second Quarter Financial Results and Recent Business Highlights
finance.yahoo.com - August 14 at 9:24 AM
finance.yahoo.com logoFMR LLC Acquires Significant Stake in Evelo Biosciences Inc
finance.yahoo.com - August 11 at 2:54 AM
msn.com logoMorgan Stanley Maintains Evelo Biosciences (EVLO) Equal-Weight Recommendation
msn.com - July 27 at 1:22 AM
benzinga.com logoWhy Are velo Biosciences Stock Is Trading Higher Today?
benzinga.com - July 21 at 12:48 PM
benzinga.com logoWhy Are Evelo Biosciences Stock Is Trading Higher Today?
benzinga.com - July 21 at 12:48 PM
marketbeat.com logo
marketbeat.com - July 21 at 9:42 AM
theglobeandmail.com logoInstrument Name Evelo Biosciences Inc Instrument Symbol (EVLO-Q)
theglobeandmail.com - July 21 at 7:48 AM
marketbeat.com logo
marketbeat.com - July 18 at 11:55 AM
finance.yahoo.com logoEvelo Biosciences Closes $25.5 Million Private Placement
finance.yahoo.com - July 12 at 8:07 AM
benzinga.com logoEvelo Biosciences shares are trading higher after the company announced a $25.5 million private placement.
benzinga.com - July 11 at 10:15 AM
marketwatch.com logoEvelo Biosciences Shares Rise 20% After Private Offering Prices
marketwatch.com - July 10 at 1:17 PM
msn.com logoEvelo Biosciences Plans $25.5M Private Placement To Fund Psoriasis Trial, Pay Down Debt
msn.com - July 10 at 1:17 PM
finance.yahoo.com logoEvelo Biosciences Announces $25.5 Million Private Placement
finance.yahoo.com - July 10 at 8:17 AM
finanznachrichten.de logoEvelo Biosciences, Inc.: Evelo Biosciences Announces Reverse Stock Split Effective
finanznachrichten.de - June 30 at 8:53 AM
msn.com logoWhy Franklin Covey Shares Are Trading Higher By 25%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
msn.com - June 29 at 3:44 PM
finance.yahoo.com logoEvelo Biosciences Announces Reverse Stock Split Effective
finance.yahoo.com - June 29 at 9:42 AM
finance.yahoo.com logoEVLO - Evelo Biosciences, Inc.
finance.yahoo.com - June 22 at 12:44 AM
investorplace.com logoWhy Is Evelo Biosciences (EVLO) Stock Up 51% Today?
investorplace.com - June 20 at 10:06 AM
benzinga.com logoEvelo Biosciences Granted U.S. Patent #11672834 For "PREBIOTIC COMPOSITIONS AND METHODS OF USE THEREOF FOR MODULATION OF THE MICROBIOME"
benzinga.com - June 15 at 7:26 PM
finance.yahoo.com logoWhat Makes Evelo Biosciences, Inc. (EVLO) a New Buy Stock
finance.yahoo.com - May 17 at 3:00 PM
finance.yahoo.com logoEvelo Biosciences Insiders Added US$575k Of Stock To Their Holdings
finance.yahoo.com - May 10 at 2:07 PM
finance.yahoo.com logoEvelo Biosciences Insiders Added US$575k Of Stock To Their Holdings \
finance.yahoo.com - May 10 at 2:07 PM
markets.businessinsider.com logoEvelo Biosciences (EVLO) Gets a Hold from Morgan Stanley
markets.businessinsider.com - April 27 at 9:28 AM
investorplace.com logoWhy Is Evelo Biosciences (EVLO) Stock Up 78% Today?
investorplace.com - April 27 at 9:09 AM
finance.yahoo.com logoFlagship-backed startup makes layoffs for second time in three months
finance.yahoo.com - April 26 at 7:40 PM
finance.yahoo.com logoEvelo Biosciences' Atopic Dermatitis Study Cohort Misses Primary Goal Again, Shuts Study, Lays Off More Staff
finance.yahoo.com - April 26 at 7:40 PM
finanznachrichten.de logoEvelo Biosciences, Inc.: Evelo Biosciences Provides Clinical Updates
finanznachrichten.de - April 26 at 9:39 AM
msn.com logoEvelo slumps ~40% as eczema drug program abandoned after trial fails; cuts staff
msn.com - April 26 at 9:39 AM
finance.yahoo.com logoEvelo Biosciences Provides Clinical Updates
finance.yahoo.com - April 26 at 9:39 AM
seekingalpha.com logoEVLO Evelo Biosciences, Inc.
seekingalpha.com - April 19 at 3:57 PM
seekingalpha.com logoEvelo Biosciences, Inc. (EVLO) Q4 2022 Earnings Call Transcript
seekingalpha.com - March 18 at 10:30 AM
finance.yahoo.com logoEvelo Biosciences Announces Fourth Quarter and Full Year 2022 Financial Results and Business Highlights
finance.yahoo.com - March 16 at 9:59 AM
msn.com logoEarnings Preview: Evelo Biosciences
msn.com - March 15 at 6:34 PM
finance.yahoo.com logoEvelo Biosciences to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, March 16, 2023
finance.yahoo.com - March 9 at 6:59 AM
finance.yahoo.com logoAfter Plunging -40.39% in 4 Weeks, Here's Why the Trend Might Reverse for Evelo Biosciences, Inc. (EVLO)
finance.yahoo.com - March 1 at 12:52 PM
finance.yahoo.com logoEvelo Biosciences to Participate in the Cowen 43rd Annual Health Care Conference
finance.yahoo.com - March 1 at 7:52 AM
finance.yahoo.com logoEvelo Biosciences Reports that EDP2939, its First Oral Extracellular Vesicle Product Candidate, Commenced Dosing in a Phase 2 Psoriasis Trial
finance.yahoo.com - February 27 at 6:13 AM
finance.yahoo.com logoDown -39.46% in 4 Weeks, Here's Why Evelo Biosciences, Inc. (EVLO) Looks Ripe for a Turnaround
finance.yahoo.com - February 13 at 2:05 PM
msn.com logoWhy WestRock Company Are Trading Lower By 13%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
msn.com - February 1 at 3:27 PM
msn.com logoEvelo Biosciences sheds 48 employees after skin disease treatment fails
msn.com - February 1 at 3:27 PM
finance.yahoo.com logoEvelo Biosciences' Atopic Dermatitis Study Fails, Observes Unusually High Placebo Response Rates
finance.yahoo.com - February 1 at 3:27 PM
finance.yahoo.com logoFlagship-backed biotech cuts nearly half its staff
finance.yahoo.com - February 1 at 3:27 PM
msn.com logoEvelo drops 23% as atopic dermatitis trial fails; announces layoffs
msn.com - February 1 at 10:27 AM
reuters.com logoEvelo Biosciences to cut jobs, skin disease drug trial disappoints
reuters.com - February 1 at 10:27 AM
finance.yahoo.com logoEvelo Biosciences Provides Clinical and Business Updates
finance.yahoo.com - February 1 at 10:26 AM
Get Evelo Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for EVLO and its competitors with MarketBeat's FREE daily newsletter.



EVLO Media Mentions By Week

EVLO Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

EVLO
News Sentiment
▼
0.44

0.69
▲
Average
Medical
News Sentiment

EVLO News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

EVLO Articles
This Week
▼
2

1
▲
EVLO Articles
Average Week

Get Evelo Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for EVLO and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:EVLO) was last updated on 10/2/2023 by MarketBeat.com Staff

My Account -